Additionally, the differential expression analysis of the GSE146726 dataset showed that IGF2BP2 loss led to the differential expression of 1040 or 920 genes in UMUC3 or J82 bladder cancer cells, respectively (Supplementary Table 6). This evidence concerns the gene IGF2BP2 and urinary bladder cancer.